Trials / Recruiting
RecruitingNCT04662918
Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding
Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding: A Prospective, International Multicenter, Observational Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- Xingshun Qi · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Acute gastrointestinal bleeding is potentially lethal in liver cirrhosis. Accurate assessment of prognosis is critical in a timely fashion. A novel model, CAGIB score, has been developed based on our Chinese multicenter retrospective study. Now, a prospective, international multicenter, observational study will be performed to further compare the performance of CAGIB versus Child-Pugh and MELD scores for evaluating the in-hospital mortality of patients with liver cirrhosis and acute gastrointestinal bleeding.
Conditions
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2020-12-10
- Last updated
- 2025-10-07
Locations
23 sites across 8 countries: United States, Brazil, China, Germany, India, Italy, Mexico, Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04662918. Inclusion in this directory is not an endorsement.